The supply agreement supports the evaluation of Immuneerings' lead product candidate, IMM-1-104, in combination with Regeneron's immunotherapy drug Libtayo in patients with advanced non-small cell ...

The supply agreement supports the evaluation of Immuneering’s lead product candidate, IMM-1-104, in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell ...

Yet ether’s underperformance comes amid other factors influencing the cryptocurrency specifically, including its circulating supply having recently risen past pre-Merge levels. The Ethereum Merge—the ...

Amazon was the last of the four major hyperscalers to report December-quarter earnings and 2025 spending plans.

There is a haunting beauty in architectural ruins. War or the passage of time has ravaged the magnificent feats of earlier civilizations.